350
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparing cigarette-cue attentional bias between people with HIV/AIDS and people with opioid use disorder who smoke

, , , &
Article: 2255028 | Received 31 Aug 2022, Accepted 28 Aug 2023, Published online: 07 Sep 2023

References

  • Bandiera, F. C., Anteneh, B., Le, T., Delucchi, K., & Guydish, J. (2015). Tobacco-related mortality among persons with mental health and substance abuse problems. PLoS One, 10(3), e0120581. https://doi.org/10.1371/journal.pone.0120581
  • Berridge, K. C. (2007). The debate over dopamine's role in reward: The case for incentive salience. Psychopharmacology, 191(3), 391–431. https://doi.org/10.1007/s00213-006-0578-x
  • Bradley, B. P., Field, M., Healy, H., & Mogg, K. (2008). Do the affective properties of smoking-related cues influence attentional and approach biases in cigarette smokers? Journal of Psychopharmacology, 22(7), 737–745. https://doi.org/10.1177/0269881107083844
  • Bradley, B. P., Mogg, K., Wright, T., & Field, M. (2003). Attentional bias in drug dependence: Vigilance for cigarette-related cues in smokers. Psychology of Addictive Behaviors, 17(1), 66–72. https://doi.org/10.1037/0893-164X.17.1.66
  • Carlson, J. M., & Fang, L. (2020). The stability and reliability of attentional bias measures in the dot-probe task: Evidence from both traditional mean bias scores and trial-level bias scores. Motivation and Emotion, 44(5), 657–669. https://doi.org/10.1007/s11031-020-09834-6
  • CDC. (n.d). Current cigarette smoking among adults in the United States. Retrieved June 23, 2021, from https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm#references
  • Chang, L., Liang, H., Kandel, S. R., & He, J. J. (2020). Independent and combined effects of nicotine or chronic tobacco smoking and HIV on the brain: A review of preclinical and clinical studies. Journal of Neuroimmune Pharmacology, 15(4), 658–693. https://doi.org/10.1007/s11481-020-09963-2
  • Christiansen, P., Mansfield, R., Duckworth, J., Field, M., & Jones, A. (2015). Internal reliability of the alcohol-related visual probe task is increased by utilising personalised stimuli and eye-tracking. Drug and Alcohol Dependence, 155, 170–174. https://doi.org/10.1016/j.drugalcdep.2015.07.672
  • Christiansen, P., Schoenmakers, T. M., & Field, M. (2015). Less than meets the eye: Reappraising the clinical relevance of attentional bias in addiction. Addictive Behaviors, 44, 43–50. https://doi.org/10.1016/j.addbeh.2014.10.005
  • Creswell, K. G., & Skrzynski, C. J. (2021). The influence of smoking motivation on the associations among cigarette craving, attentional bias to smoking cues, and smoking behavior. Nicotine & Tobacco Research, 23(10), 1727–1734. https://doi.org/10.1093/ntr/ntab028
  • Ehrman, R. N., Robbins, S. J., Bromwell, M. A., Lankford, M. E., Monterosso, J. R., & O'Brien, C. P. (2002). Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug and Alcohol Dependence, 67(2), 185–191. https://doi.org/10.1016/S0376-8716(02)00065-0
  • Elkader, A. K., Brands, B., Selby, P., & Sproule, B. A. (2009). Methadone-nicotine interactions in methadone maintenance treatment patients. Journal of Clinical Psychopharmacology, 29(3), 231–238. https://doi.org/10.1097/JCP.0b013e3181a39113
  • Engelmann, J. M., Versace, F., Robinson, J. D., Minnix, J. A., Lam, C. Y., Cui, Y., Brown, V. L., Cinciripini, P. M., (2012). Neural substrates of smoking cue reactivity: A meta-analysis of fMRI studies. Neuroimage, 60(1), 252–262. https://doi.org/10.1016/j.neuroimage.2011.12.024
  • Field, M., & Cox, W. M. (2008). Attentional bias in addictive behaviors: A review of its development, causes, and consequences. Drug and Alcohol Dependence 97(1–2), 1–20. https://doi.org/10.1016/j.drugalcdep.2008.03.030
  • Guydish, J., Passalacqua, E., Tajima, B., Chan, M., Chun, J., & Bostrom, A. (2011). Smoking prevalence in addiction treatment: A review. Nicotine & Tobacco Research, 13(6), 401–411. https://doi.org/10.1093/ntr/ntr048
  • Helleberg, M., May, M. T., Ingle, S. M., Dabis, F., Reiss, P., Fätkenheuer, G., Costagliola, D., d’Arminio, A., Cavassini, M., Smith, C., Justice, A. C., Gill, J., Sterne, J. A. C., Obel, N. (2015). Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. Aids (London, England), 29(2), 221–229. https://doi.org/10.1097/QAD.0000000000000540
  • HIV.gov. (n.d). U.S. statistics. https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics
  • Hser, Y. I., McCarthy, W. J., & Anglin, M. D. (1994). Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Preventive Medicine, 23(1), 61–69. https://doi.org/10.1006/pmed.1994.1009
  • Jasinska, A. J., Stein, E. A., Kaiser, J., Naumer, M. J., & Yalachkov, Y. (2014). Factors modulating neural reactivity to drug cues in addiction: A survey of human neuroimaging studies. Neuroscience & Biobehavioral Reviews, 38, 1–16. https://doi.org/10.1016/j.neubiorev.2013.10.013
  • Judd, C. M., Westfall, J., & Kenny, D. A. (2017). Experiments with more than one random factor: Designs, analytic models, and statistical power. Annual Review of Psychology, 68(1), 601–625. https://doi.org/10.1146/annurev-psych-122414-033702
  • Kohut, S. J. (2017). Interactions between nicotine and drugs of abuse: A review of preclinical findings. The American Journal of Drug and Alcohol Abuse, 43(2), 155–170. https://doi.org/10.1080/00952990.2016.1209513
  • Kuwabara, H., Heishman, S. J., Brasic, J. R., Contoreggi, C., Cascella, N., Mackowick, K. M., Taylor, R., Rousset, O., Willis, W., Huestis, M. A., Concheiro, M., Wand, G., Wong, D. F., Volkow, N. D. (2014). Mu opioid receptor binding correlates with nicotine dependence and reward in smokers. PLoS One, 9(12), e113694. https://doi.org/10.1371/journal.pone.0113694
  • Lifson, A. R., & Lando, H. A. (2012). Smoking and HIV: Prevalence, health risks, and cessation strategies. Current HIV/AIDS Reports, 9(3), 223–230. https://doi.org/10.1007/s11904-012-0121-0
  • Lin, X., Deng, J., Shi, L., Wang, Q., Li, P., Li H., Liu, J., Que, J., Chang, S., Bao, Y., Shi, J., Weinberger, D. R., Wu, P., Lu, L. (2020). Neural substrates of smoking and reward cue reactivity in smokers: A meta-analysis of fMRI studies. Translational Psychiatry 10(1), 97. https://doi.org/10.1038/s41398-020-0775-0
  • Manoliu, A., Haugg, A., Sladky, R., Hulka, L., Kirschner, M., Brühl, A. B., Seifritz, E., Quednow, B., Herdener, M., Scharnowski, F. (2021). Smocuda: A validated smoking cue database to reliably induce craving in tobacco use disorder. European Addiction Research, 27(2), 107–114. https://doi.org/10.1159/000509758
  • Marks, K. R., Alcorn, J., III, Stoops, W. W., & Rush, C. R. (2016). Cigarette Cue attentional bias in cocaine-smoking and non-cocaine-using cigarette smokers. Nicotine & Tobacco Research, 18(9), 1915–1919. https://doi.org/10.1093/ntr/ntw026
  • Marks, K. R., Pike, E., Stoops, W. W., & Rush, C. R. (2015). The magnitude of drug attentional bias is specific to substance use disorder. Psychology of Addictive Behaviors, 29(3), 690–695. https://doi.org/10.1037/adb0000084
  • Marks, K. R., Roberts, W., Stoops, W. W., Pike, E., Fillmore, M. T., & Rush, C. R. (2014). Fixation time is a sensitive measure of cocaine cue attentional bias. Addiction, 109(9), 1501–1508. https://doi.org/10.1111/add.12635
  • Masiero, M., Lucchiari, C., Maisonneuve, P., Pravettoni, G., Veronesi, G., & Mazzocco, K. (2019). The attentional bias in current and former smokers. Frontiers in Behavioral Neuroscience, 13(154), https://doi.org/10.3389/fnbeh.2019.00154
  • McGehee, D. S. (2006). Nicotinic and opioid receptor interactions in nicotine addiction. Molecular Interventions, 6(6), 311–314. https://doi.org/10.1124/mi.6.6.4
  • McHugh, R. K. (2020). The importance of studying Sex and gender differences in opioid misuse. JAMA Network Open, 3(12), e2030676. https://doi.org/10.1001/jamanetworkopen.2020.30676
  • Mogg, K., Bradley, B. P., Field, M., & De Houwer, J. (2003). Eye movements to smoking-related pictures in smokers: Relationship between attentional biases and implicit and explicit measures of stimulus valence. Addiction, 98(6), 825–836. https://doi.org/10.1046/j.1360-0443.2003.00392.x
  • Mutschler, N. H., Stephen, B. J., Teoh, S. K., Mendelson, J. H., & Mello, N. K. (2002). An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids. Nicotine & Tobacco Research, 4(2), 223–228. https://doi.org/10.1080/14622200210124012
  • Nahvi, S., Ning, Y., Segal, K. S., Richter, K. P., & Arnsten, J. H. (2014). Varenicline efficacy and safety among methadone maintained smokers: A randomized placebo-controlled trial. Addiction, 109(9), 1554–1563. https://doi.org/10.1111/add.12631
  • Nahvi, S., Richter, K., Li, X., Modali, L., & Arnsten, J. (2006). Cigarette smoking and interest in quitting in methadone maintenance patients. Addictive Behaviors, 31(11), 2127–2134. https://doi.org/10.1016/j.addbeh.2006.01.006
  • Pacek, L. R., & Crum, R. M. (2015). A review of the literature concerning HIV and cigarette smoking: Morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts. Addiction Research & Theory, 23(1), 10–23. https://doi.org/10.3109/16066359.2014.920013
  • Pacek, L. R., Latkin, C., Crum, R. M., Stuart, E. A., & Knowlton, A. R. (2014). Current cigarette smoking among HIV-positive current and former drug users: Associations with individual and social characteristics. AIDS and Behavior, 18(7), 1368–1377. https://doi.org/10.1007/s10461-013-0663-1
  • Reddy, K. P., Kong, C. Y., Hyle, E. P., Baggett, T. P., Huang, M., Parker, R. A., Paltiel, A. D., Losina, E., Weinstein, M. C., Freedberg, K. A., Walensky, R. P. (2017). Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States. JAMA Internal Medicine, 177(11), 1613–1621. https://doi.org/10.1001/jamainternmed.2017.4349
  • Richter, K. P., Hamilton, A. K., Hall, S., Catley, D., Cox, L. S., & Grobe, J. (2007). Patterns of smoking and methadone dose in drug treatment patients. Experimental and Clinical Psychopharmacology, 15(2), 144–153. https://doi.org/10.1037/1064-1297.15.2.144
  • Stein, M. D., Caviness, C. M., Kurth, M. E., Audet, D., Olson, J., & Anderson, B. J. (2013). Varenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial. Drug and Alcohol Dependence, 133(2), 486–493. https://doi.org/10.1016/j.drugalcdep.2013.07.005
  • Wang, T. W., Asman, K., Gentzke, A. S., Cullen, K. A., Holder-Hayes, E., Reyes-Guzman, C., Jamal, A., Neff, L., & King, B. A. (2018). Tobacco product use among adults – United States, 2017. MMWR. Morbidity and Mortality Weekly Report, 67(44), 1225–1232. https://doi.org/10.15585/mmwr.mm6744a2
  • Waters, A. J., Shiffman, S., Bradley, B. P., & Mogg, K. (2003). Attentional shifts to smoking cues in smokers. Addiction, 98(10), 1409–1417. https://doi.org/10.1046/j.1360-0443.2003.00465.x
  • Yang, M. J., Borges, A. M., Emery, N. N., & Leyro, T. M. (2022). Trial-level bias score versus mean bias score: Comparison of the reliability and external validity using dot-probe task among daily smokers. Addictive Behaviors, 135, 107456. https://doi.org/10.1016/j.addbeh.2022.107456
  • Yoon, J. H., Lane, S. D., & Weaver, M. F. (2015). Opioid analgesics and nicotine: More than blowing smoke. Journal of Pain & Palliative Care Pharmacotherapy, 29(3), 281–289. https://doi.org/10.3109/15360288.2015.1063559
  • Zilverstand, A., Huang, A. S., Alia-Klein, N., & Goldstein, R. Z. (2018). Neuroimaging impaired response inhibition and salience attribution in human drug addiction: A systematic review. Neuron, 98(5), 886–903. https://doi.org/10.1016/j.neuron.2018.03.048